Bangladesh vs Papua New Guinea: Previously treated cases tested for RR-/MDR-TB
Bangladesh
100.0%
in 2024
Papua New Guinea
100.0%
in 2024
Bangladesh rank
1st
Papua New Guinea rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Bangladesh
- Papua New Guinea
How they compare
Bangladesh currently reports 100.0% against 100.0% in Papua New Guinea, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2015 it was Bangladesh ahead.
Bangladesh ranks 1st and Papua New Guinea ranks 1st of 180 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Papua New Guinea in 1.
Head to head by decade
| Decade | Bangladesh | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.7% | 43.3% | 19.3% | Bangladesh |
| 2020s | 92.5% | 100.0% | 7.5% | Papua New Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bangladesh or Papua New Guinea?
- Bangladesh, at 100.0% against 100.0% in Papua New Guinea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bangladesh and Papua New Guinea?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Papua New Guinea?
- 5 years are reported by both, from 2015 to 2024.
- How do Bangladesh and Papua New Guinea rank globally for previously treated cases tested for rr-/mdr-tb?
- Bangladesh ranks 1st and Papua New Guinea ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.